Daiwa Securities Group
DFTX

Daiwa Securities Group’s Definium Therapeutics DFTX Stock Holding History

Daiwa Securities Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-242
Closed -$3K – 1341
2025
Q4 		$3K Hold
242
– – ﹤0.01% 1280
2025
Q3 		$3K Hold
242
– – ﹤0.01% 1243
2025
Q2 		$2K Hold
242
– – ﹤0.01% 1219
2025
Q1 		$1K Hold
242
– – ﹤0.01% 1234
2024
Q4 		$2K Buy
+242
New +$1.67K ﹤0.01% 1221

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Daiwa Securities Group's DFTX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Definium Therapeutics (DFTX) in Q1 2026, closing a stake of 242 shares — an estimated $3K sold.

Daiwa Securities Group first reported a position in DFTX in Q4 2024 and held it in 5 quarters. The position peaked at $3K in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Definium Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 242 Definium Therapeutics shares in Q1 2026, an estimated $3K.
  • Daiwa Securities Group first reported a position in Definium Therapeutics in Q4 2024 and held it in 5 quarters.
  • Daiwa Securities Group's Definium Therapeutics position peaked at $3K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.